Compound 451
Identifiers
- Canonical SMILES:
COC(=O)c1ccc(cc1)-n1[nH]c2c3cnn(C)c3nc(-c3cccc(c3)C(F)(F)F)c2c1=O
- InChi:
InChI=1S/C23H16F3N5O3/c1-30-20-16(11-27-30)19-17(18(28-20)13-4-3-5-14(10-13)23(24,25)26)21(32)31(29-19)15-8-6-12(7-9-15)22(33)34-2/h3-11,29H,1-2H3
- InChiKey:
QPXFMWQAORRHBW-UHFFFAOYSA-N
External links
168318210 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 7.51 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 467.12 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 5.00 | |||
TPSA | 89.35 | |||
RB | 5 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4850 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4833 | Riociguat | DB08931 | |
0.4823 | ATX-914 | DB12673 | |
0.4677 | Vericiguat | DB15456 | |
0.4646 | Decoglurant | DB11923 | |
0.4558 | MK-0249 | DB11910 | |
0.4553 | Tepotinib | DB15133 | |
0.4531 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4517 | Risdiplam | DB15305 | |
0.4511 | Dilmapimod | DB12140 | |
0.4500 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4424 | Telmisartan | DB00966 | |
0.4414 | 3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB07210 | |
0.4400 | 5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08531 | |
0.4384 | ABT-288 | DB15192 |